Gynecologic oncology reports
Audio Summaries

Response to progestin-based therapy in endometrial intraepithelial neoplasia: An exploratory biomarker study

Jun 22, 2026

This study aimed to investigate the relationship between baseline tissue biomarker expression and the response to progestin-based therapy in premenopausal women with endometrial intraepithelial neoplasia (EIN). The authors found that lower baseline expression of progesterone receptor A (PR-A) was associated with treatment resistance, while a pre-treatment PR-A:PR-B ratio of ≤ 1 indicated a higher likelihood of progesterone resistance. These findings suggest that progesterone receptor expression patterns may help predict treatment outcomes, highlighting the need for further validation in larger studies.

Vaginal dilator therapy for pelvic cancer patients: a review

Jun 22, 2026

This review examines the effectiveness of vaginal dilator therapy for pelvic cancer patients suffering from vulvovaginal atrophy, which is exacerbated by cancer treatments that induce estrogen deficiency. The authors aim to determine how this therapy can prevent complications such as vaginal stenosis and improve sexual function, while also addressing the challenges of patient adherence to the recommended usage. They suggest that enhanced education and support may improve adherence and therapeutic outcomes.

Improving postoperative outcomes in gynecologic oncology through a standardized telehealth intervention: experience from an urban safety-net hospital system

Jun 22, 2026

The authors aimed to evaluate the effectiveness of a standardized postoperative phone call program on improving outcomes for patients undergoing gynecologic oncology surgery at an urban safety-net hospital. The study found that patients who received follow-up calls had significantly higher rates of postoperative visit attendance and outpatient management of complications, while also showing a trend towards lower mortality rates, indicating that such interventions may enhance care coordination and patient outcomes.

The effect of polyallergy on ancillary service use among postoperative patients with gynecologic malignancies

Jun 19, 2026

The authors aimed to investigate whether polyallergy, defined as having four or more documented allergies, is an independent predictor of ancillary service use among postoperative patients with gynecologic malignancies. Their study found that patients with polyallergy had significantly higher rates of ancillary service encounters compared to those without, suggesting that these patients may benefit from enhanced primary care and psychological support to mitigate increased healthcare utilization.

Hypercalcemia in poorly differentiated endometrial cancer: a report of two cases

Jun 17, 2026

The authors investigate the occurrence of hypercalcemia in poorly differentiated endometrial cancer, specifically examining its relationship with elevated parathyroid hormone (PTH) levels in the absence of parathyroid disease or bone metastases. They present two case studies that illustrate how hypercalcemia correlates with tumor progression and highlight the importance of considering ectopic PTH secretion in such patients to ensure accurate diagnosis and management.

The impact on sexual wellbeing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer treatment

Jun 17, 2026

The authors aimed to evaluate the impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) on the sexual wellbeing of ovarian cancer survivors. Their study found that a significant majority of patients reported negative changes in sexual wellbeing post-treatment, with only a third receiving relevant healthcare support, which was associated with higher sexual satisfaction. The findings highlight the need for improved attention to sexual health in the survivorship care of ovarian cancer patients.

Vaginal cancer in the second trimester of pregnancy: Successful conservative surgery and 21-year disease-free survival

Jun 17, 2026

The authors investigate the management of primary vaginal cancer diagnosed during pregnancy, a rare condition with no standardized treatment protocols. They present a case of a 38-year-old woman who underwent successful conservative surgery in the second trimester, leading to a healthy delivery and 21 years of disease-free survival, suggesting that careful selection and multidisciplinary decision-making can facilitate effective treatment while preserving fetal health.

Improvement in chronic lymphedema in a gynecologic cancer survivor after starting GLP-1 receptor agonist therapy: A case report

Jun 17, 2026

This case report investigates the potential benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in treating chronic lower extremity and pelvic lymphedema in a gynecologic cancer survivor. The authors present a patient with severe lymphedema who experienced significant improvement in symptoms and quality of life after starting GLP-1 RA therapy, suggesting that these medications may offer a new treatment avenue for this challenging condition. The report highlights the need for further research to explore the effectiveness of GLP-1 RAs in managing lower extremity lymphedema.

Ecthyma gangrenosum in a patient with metastatic leiomyosarcoma undergoing chemotherapy: a case report

Jun 15, 2026

The authors present a case of ecthyma gangrenosum (EG) in a 40-year-old patient with metastatic leiomyosarcoma undergoing chemotherapy, aiming to highlight the clinical presentation and management of EG in immunocompromised individuals. They demonstrate that EG can occur without systemic symptoms and emphasize the importance of early detection and prompt antibiotic treatment to prevent complications in vulnerable patients. This case adds to the limited literature on EG in patients with gynecologic malignancies.

Impact of preoperative frailty assessment on peri-operative complications and cancer related outcomes in advanced stage endometrial cancer

Jun 15, 2026

This study aimed to evaluate the relationship between preoperative frailty, as measured by the modified frailty index, and postoperative complications in patients with advanced-stage endometrial cancer undergoing hysterectomy. The findings indicated that frailty did not correlate with increased complication rates or poorer survival outcomes, suggesting that the minimally invasive surgical approach may mitigate the negative effects of frailty. However, the authors acknowledge the limitations of their small sample size and call for larger, multi-institutional studies to further explore this issue.